A schematic illustration of Roche instrumentation in the new laboratory space on the fourth floor of The Vanderbilt Clinic. The clinical testing platform includes the first U.S. installation of the cobas c 703 and cobas ISE neo analytical units. (illustration courtesy of Roche Diagnostics)
Beginning Nov. 13, Vanderbilt Medical Laboratories (VML) at the Vanderbilt Clinic (TVC) will relocate to Suite 4915.
View a map of the new laboratory location at TVC4.
As part of the broader VML transformation, the new laboratory will transition chemistry and immunoassay testing to Roche cobas automation. This change will expand capacity, improve workflow efficiency, and support consistent, high-quality laboratory testing.
How Will This Affect Laboratory Testing?
This transition will affect inpatient testing from the Main Campus and STAT testing for ambulatory clinics sent to the Main Campus.
The process for ordering laboratory tests will remain unchanged. However, the new instrumentation may affect certain reference intervals, specimen and collection tube requirements, analytical measurement characteristics, reportable ranges, and how results trend within Epic.
Additional information is available in the following resources:
Questions about the laboratory relocation or testing changes: please contact 2026TVCLabMove@vumc.org.
